-
1
-
-
0038512034
-
Recurrent primary biliary cirrhosis
-
Neuberger J. Recurrent primary biliary cirrhosis. Liver Transpl 2003, 9:539-46.
-
(2003)
Liver Transpl
, vol.9
, pp. 539-546
-
-
Neuberger, J.1
-
2
-
-
34648843072
-
Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation
-
Charatcharoenwitthaya P, Pimentel S, Talwalkar JA. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation. Liver Transpl 2007, 13:1236-45.
-
(2007)
Liver Transpl
, vol.13
, pp. 1236-1245
-
-
Charatcharoenwitthaya, P.1
Pimentel, S.2
Talwalkar, J.A.3
et al4
-
3
-
-
27244448261
-
Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant
-
Guy JE, Qian P, Lowell JA, Peters MG. Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant. Liver Transpl 2005, 11:1252-7.
-
(2005)
Liver Transpl
, vol.11
, pp. 1252-1257
-
-
Guy, J.E.1
Qian, P.2
Lowell, J.A.3
Peters, M.G.4
-
4
-
-
33646019203
-
Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients
-
Jacob DA, Neumann UP, Bahra M. Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients. Clin Transpl 2006, 20:211-20.
-
(2006)
Clin Transpl
, vol.20
, pp. 211-220
-
-
Jacob, D.A.1
Neumann, U.P.2
Bahra, M.3
et al4
-
5
-
-
0038824919
-
The effect of immunosuppressive regimens on the recurrence of primary biliary cirrhosis after liver transplantation
-
Levitsky J, Hart J, Cohen SM, Te HS. The effect of immunosuppressive regimens on the recurrence of primary biliary cirrhosis after liver transplantation. Liver Transpl 2003, 9:733-6.
-
(2003)
Liver Transpl
, vol.9
, pp. 733-736
-
-
Levitsky, J.1
Hart, J.2
Cohen, S.M.3
Te, H.S.4
-
6
-
-
1842529225
-
Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation
-
Neuberger J, Gunson B, Hubscher S, Nightingale P. Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation. Liver Transpl 2004, 10:488-91.
-
(2004)
Liver Transpl
, vol.10
, pp. 488-491
-
-
Neuberger, J.1
Gunson, B.2
Hubscher, S.3
Nightingale, P.4
-
7
-
-
10744222144
-
The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation
-
Sanchez EQ, Levy MF, Goldstein RM. The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation. Transplantation 2003, 76:1583-8.
-
(2003)
Transplantation
, vol.76
, pp. 1583-1588
-
-
Sanchez, E.Q.1
Levy, M.F.2
Goldstein, R.M.3
et al4
-
8
-
-
77949809029
-
Cyclosporine a protects against primary biliary cirrhosis recurrence after liver transplantation
-
Montano-Loza AJ, Wasilenko S, Bintner J, Mason AL. Cyclosporine a protects against primary biliary cirrhosis recurrence after liver transplantation. Am J Transplant 2010, 10:852-8.
-
(2010)
Am J Transplant
, vol.10
, pp. 852-858
-
-
Montano-Loza, A.J.1
Wasilenko, S.2
Bintner, J.3
Mason, A.L.4
-
9
-
-
33745336579
-
Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis
-
McAlister VC, Haddad E, Renouf E. Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis. Am J Transplant 2006, 6:1578-85.
-
(2006)
Am J Transplant
, vol.6
, pp. 1578-1585
-
-
McAlister, V.C.1
Haddad, E.2
Renouf, E.3
et al4
-
10
-
-
34247394118
-
New insights from recurrent primary biliary cirrhosis in liver transplantation: the paradox of BEComing a fibroblast?
-
Wasilenko S, Mason AL. New insights from recurrent primary biliary cirrhosis in liver transplantation: the paradox of BEComing a fibroblast? Hepatology 2007, 45:837-40.
-
(2007)
Hepatology
, vol.45
, pp. 837-840
-
-
Wasilenko, S.1
Mason, A.L.2
-
11
-
-
67149095289
-
Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants
-
Hirschfield GM, Liu X, Xu C. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 2009, 360:2544-55.
-
(2009)
N Engl J Med
, vol.360
, pp. 2544-2555
-
-
Hirschfield, G.M.1
Liu, X.2
Xu, C.3
et al4
-
12
-
-
39549115685
-
The causes of primary biliary cirrhosis: convenient and inconvenient truths
-
Gershwin ME, Mackay IR. The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology 2008, 47:737-45.
-
(2008)
Hepatology
, vol.47
, pp. 737-745
-
-
Gershwin, M.E.1
Mackay, I.R.2
-
13
-
-
9644270286
-
Patients with primary biliary cirrhosis make anti-viral and anti-mitochondrial antibodies to mouse mammary tumor virus
-
Mason A, Xu L, Shen Z. Patients with primary biliary cirrhosis make anti-viral and anti-mitochondrial antibodies to mouse mammary tumor virus. Gastroenterology 2004, 127:1863-4.
-
(2004)
Gastroenterology
, vol.127
, pp. 1863-1864
-
-
Mason, A.1
Xu, L.2
Shen, Z.3
et al4
-
14
-
-
67049159544
-
Primary biliary cirrhosis, bacteria and molecular mimicry: what's the molecule and where's the mimic?
-
Wasilenko ST, Mason GE, Mason AL. Primary biliary cirrhosis, bacteria and molecular mimicry: what's the molecule and where's the mimic? Liver Int 2009, 29:779-82.
-
(2009)
Liver Int
, vol.29
, pp. 779-782
-
-
Wasilenko, S.T.1
Mason, G.E.2
Mason, A.L.3
-
15
-
-
0038153863
-
Does a betaretrovirus infection trigger primary biliary cirrhosis?
-
Xu L, Shen Z, Guo L. Does a betaretrovirus infection trigger primary biliary cirrhosis? Proc Natl Acad Sci USA 2003, 100:8454-9.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 8454-8459
-
-
Xu, L.1
Shen, Z.2
Guo, L.3
et al4
-
16
-
-
0029858363
-
Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis
-
Van de Water J, Gerson LB, Ferrell LD. Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis. Hepatology 1996, 24:1079-84.
-
(1996)
Hepatology
, vol.24
, pp. 1079-1084
-
-
Van de Water, J.1
Gerson, L.B.2
Ferrell, L.D.3
et al4
-
17
-
-
33645106470
-
Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation
-
Firpi RJ, Zhu H, Morelli G. Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation. Liver Transpl 2006, 12:51-5.
-
(2006)
Liver Transpl
, vol.12
, pp. 51-55
-
-
Firpi, R.J.1
Zhu, H.2
Morelli, G.3
et al4
-
19
-
-
21244433445
-
Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase
-
Watashi K, Ishii N, Hijikata M. Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase. Mol Cell 2005, 19:111-22.
-
(2005)
Mol Cell
, vol.19
, pp. 111-122
-
-
Watashi, K.1
Ishii, N.2
Hijikata, M.3
et al4
-
20
-
-
0027940713
-
Specific incorporation of cyclophilin A into HIV-1 virions
-
Franke EK, Yuan HE, Luban J. Specific incorporation of cyclophilin A into HIV-1 virions. Nature 1994, 372:359-62.
-
(1994)
Nature
, vol.372
, pp. 359-362
-
-
Franke, E.K.1
Yuan, H.E.2
Luban, J.3
-
21
-
-
0030219974
-
Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction
-
Franke EK, Luban J. Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction. Virology 1996, 222:279-82.
-
(1996)
Virology
, vol.222
, pp. 279-282
-
-
Franke, E.K.1
Luban, J.2
-
22
-
-
33745316971
-
Novel activities of cyclophilin A and cyclosporin A during HIV-1 infection of primary lymphocytes and macrophages
-
Saini M, Potash MJ. Novel activities of cyclophilin A and cyclosporin A during HIV-1 infection of primary lymphocytes and macrophages. J Immunol 2006, 177:443-9.
-
(2006)
J Immunol
, vol.177
, pp. 443-449
-
-
Saini, M.1
Potash, M.J.2
-
23
-
-
1442355465
-
Cloning the human betaretrovirus proviral genome from patients with primary biliary cirrhosis
-
Xu L, Sakalian M, Shen Z. Cloning the human betaretrovirus proviral genome from patients with primary biliary cirrhosis. Hepatology 2004, 39:151-6.
-
(2004)
Hepatology
, vol.39
, pp. 151-156
-
-
Xu, L.1
Sakalian, M.2
Shen, Z.3
et al4
-
24
-
-
0019451205
-
Changes in retrovirus expression in mouse mammary tumor cells in culture
-
Arya S. Changes in retrovirus expression in mouse mammary tumor cells in culture. Cancer Res 1981, 41:1579-84.
-
(1981)
Cancer Res
, vol.41
, pp. 1579-1584
-
-
Arya, S.1
-
25
-
-
33748687426
-
NIM811, a cyclophilin inhibitor, exhibits potent in vitro activity against hepatitis C virus alone or in combination with alpha interferon
-
Ma S, Boerner JE, TiongYip C. NIM811, a cyclophilin inhibitor, exhibits potent in vitro activity against hepatitis C virus alone or in combination with alpha interferon. Antimicrob Agents Chemother 2006, 50:2976-82.
-
(2006)
Antimicrob Agents Chemother
, vol.50
, pp. 2976-2982
-
-
Ma, S.1
Boerner, J.E.2
TiongYip, C.3
et al4
-
26
-
-
33749174135
-
Lopinavir/ritonavir exposure in treatment-naive HIV-infected children following twice or once daily administration
-
Rosso R, Di Biagio A, Dentone C. Lopinavir/ritonavir exposure in treatment-naive HIV-infected children following twice or once daily administration. J Antimicrob Chemother 2006, 57:1168-71.
-
(2006)
J Antimicrob Chemother
, vol.57
, pp. 1168-1171
-
-
Rosso, R.1
Di Biagio, A.2
Dentone, C.3
et al4
-
27
-
-
34547452686
-
Reverse transcriptase activity in patients with primary biliary cirrhosis and other autoimmune liver disorders
-
McDermid J, Chen M, Li Y. Reverse transcriptase activity in patients with primary biliary cirrhosis and other autoimmune liver disorders. Aliment Pharmacol Ther 2007, 26:587-95.
-
(2007)
Aliment Pharmacol Ther
, vol.26
, pp. 587-595
-
-
McDermid, J.1
Chen, M.2
Li, Y.3
et al4
-
28
-
-
0038287894
-
Correlation and simple linear regression
-
Zou KH, Tuncali K, Silverman SG. Correlation and simple linear regression. Radiology 2003, 227:617-22.
-
(2003)
Radiology
, vol.227
, pp. 617-622
-
-
Zou, K.H.1
Tuncali, K.2
Silverman, S.G.3
-
29
-
-
62449220793
-
Overview of biostatistics used in clinical research
-
De Muth JE. Overview of biostatistics used in clinical research. Am J Health Syst Pharm 2009, 66:70-81.
-
(2009)
Am J Health Syst Pharm
, vol.66
, pp. 70-81
-
-
De Muth, J.E.1
-
30
-
-
71049114184
-
Isolation of a human betaretrovirus resembling mouse mammary tumor virus (MMTV) from patients with primary biliary cirrhosis (abstract)
-
Indik S, Mojiri A, Wong I. Isolation of a human betaretrovirus resembling mouse mammary tumor virus (MMTV) from patients with primary biliary cirrhosis (abstract). Retrovirology 2009, 6((Suppl. 2)):P55.
-
(2009)
Retrovirology
, vol.6
, Issue.SUPPL. 2
-
-
Indik, S.1
Mojiri, A.2
Wong, I.3
et al4
-
31
-
-
70049096419
-
Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics
-
Kaul A, Stauffer S, Berger C. Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics. PLoS Patho 2009, 5:e1000546.
-
(2009)
PLoS Patho
, vol.5
-
-
Kaul, A.1
Stauffer, S.2
Berger, C.3
et al4
-
32
-
-
50949096105
-
Combinations of cyclophilin inhibitor NIM811 with hepatitis C Virus NS3-4A Protease or NS5B polymerase inhibitors enhance antiviral activity and suppress the emergence of resistance
-
Mathy JE, Ma S, Compton T, Lin K. Combinations of cyclophilin inhibitor NIM811 with hepatitis C Virus NS3-4A Protease or NS5B polymerase inhibitors enhance antiviral activity and suppress the emergence of resistance. Antimicrob Agents Chemother 2008, 52:3267-75.
-
(2008)
Antimicrob Agents Chemother
, vol.52
, pp. 3267-3275
-
-
Mathy, J.E.1
Ma, S.2
Compton, T.3
Lin, K.4
-
33
-
-
59349118957
-
Mouse mammary tumour virus-like virus (MMTV-LV) is present within the liver in a wide range of hepatic disorders and unrelated to nuclear p53 expression or hepatocarcinogenesis
-
Johal H, Scott GM, Jones R. Mouse mammary tumour virus-like virus (MMTV-LV) is present within the liver in a wide range of hepatic disorders and unrelated to nuclear p53 expression or hepatocarcinogenesis. J Hepatol 2009, 50:548-54.
-
(2009)
J Hepatol
, vol.50
, pp. 548-554
-
-
Johal, H.1
Scott, G.M.2
Jones, R.3
et al4
-
34
-
-
4143106857
-
Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis
-
Selmi C, Ross SR, Ansari AA. Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis. Gastroenterology 2004, 127:493-501.
-
(2004)
Gastroenterology
, vol.127
, pp. 493-501
-
-
Selmi, C.1
Ross, S.R.2
Ansari, A.A.3
et al4
|